Efficacy of capecitabine combined with intrahepatic transcatheter arterial chemo embolization in primary hepatic carcinoma
- VernacularTitle:卡培他滨联合肝动脉栓塞化疗治疗原发性肝癌
- Author:
Yuling WANG
;
Caifang NI
;
Yizhi LIU
- Publication Type:Journal Article
- Keywords:
primary hepatic carcinoma;
capecitabine;
chem oembolization therapy
- From:
China Oncology
2000;0(06):-
- CountryChina
- Language:Chinese
-
Abstract:
Purpose:To observe the efficacy of capecitabi ne combined with the transcatheter arterial chemoembolization (TACE) in late-stag e primary hepatic carcinoma.Methods:62 patients of late-stage hepatic carcinoma (TNM: Ⅱ- Ⅳ) were divided into two groups at random:①Simple TACE group: 30 cases;②capec itabine+TACE group:32 cases were given additional oral capecitabine for 14 days the next day after TACE therapy. All the patients were followed for two years.Th e median survival time, the average survival time of dead patients, the 1-year survival rate and the second-stage surgical resection rate of the two groups we re compared. Results:The median survival time of capecitabine+TACE group was 14.5 months, the 1-year survival rate 75%, the second-stage surgical resectio n rate 25%; the TACE group was 6 months,39.3%,6.7% ,respectively. The difference was significant (P
